Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.

被引：0
|
作者：
De Ledinghen, V
Trimoulet, P
Winnock, M
Bernard, PH
Bourliere, M
Portal, I
Remy, AJ
Canva, V
Levy, S
Foucher, J
Chene, G
Couzigou, P
机构：
[1] Hop Haut Leveque, Pessac, France
[2] INSERM, U330, Bordeaux, France
来源：
HEPATOLOGY | 2001年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1655
引用
收藏
页码：586A / 586A
页数：1
相关论文
共 50 条
  • [31] Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C
    Wong, JB
    Davis, GL
    Pauker, SG
    AMERICAN JOURNAL OF MEDICINE, 2000, 108 (05): : 366 - 373
  • [32] Interferon ALFA-2B (IFN-a2B)/ribavirin compared to consensus interferon (CIFN)/ribavirin in treatment of chronic hepatitis C
    Sjogren, MH
    Holtzmuller, K
    Sjogren, RW
    JOURNAL OF HEPATOLOGY, 2001, 34 : 234 - 234
  • [33] Efficacy of ribavirin monotherapy following combination therapy with interferon alfa-2b and ribavirin for patients with chronic hepatitis C
    Nagayama, A
    Tanaka, A
    Ankoh, H
    Narita, T
    Izumi, M
    Miyake, K
    Takikawa, H
    HEPATOLOGY RESEARCH, 2005, 32 (02) : 101 - 106
  • [34] Ribavirin plus alfa interferon in the treatment of chronic hepatitis C unresponsive to alfa interferon alone. Evaluation of response in terms of ALT values and quantitative viraemia.
    Benetti, GP
    Tagger, A
    Ramella, G
    Ribero, ML
    Quagliuolo, M
    Gucciardo, E
    Merlini, R
    HEPATOLOGY, 1996, 24 (04) : 1426 - 1426
  • [35] Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapy
    Lo Iacono, O
    Castro, A
    Diago, M
    Moreno, JA
    Fernandez-Bermejo, M
    Vega, P
    García, V
    Carbonell, P
    Sanz, P
    Borque, MJ
    García-Buey, L
    García-Monzón, C
    Pedreira, J
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (04) : 463 - 469
  • [36] COMBINED TREATMENT WITH INTERFERON-ALPHA-2B AND RIBAVIRIN FOR CHRONIC HEPATITIS-C IN PATIENTS WITH A PREVIOUS NONRESPONSE OR NONSUSTAINED RESPONSE TO INTERFERON ALONE
    SCHVARCZ, R
    YUN, ZB
    SONNERBORG, A
    WEILAND, O
    JOURNAL OF MEDICAL VIROLOGY, 1995, 46 (01) : 43 - 47
  • [37] Ribavirin plus alfa-interferon and ribavirin alone in resistant chronic hepatitis C
    Tripi, S
    DiGaetano, G
    Montalto, G
    Soresi, M
    Ortoleva, A
    Migneco, G
    HEPATOLOGY, 1996, 24 (04) : 1857 - 1857
  • [38] Treatment of chronic hepatitis B and hepatitis C with interferon alfa-2b
    Molloy, PJ
    Azzouz, M
    VanThiel, DH
    AMERICAN FAMILY PHYSICIAN, 1996, 54 (05) : 1598 - 1602
  • [39] Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children:: Efficacy, safety, and pharmacokinetics
    González-Peralta, RP
    Kelly, DA
    Haber, B
    Molleston, J
    Murray, KF
    Jonas, MM
    Shelton, M
    Mieli-Vergani, G
    Lurie, Y
    Martin, S
    Lang, T
    Baczkowski, A
    Geffner, M
    Gupta, S
    Laughlin, M
    HEPATOLOGY, 2005, 42 (05) : 1010 - 1018
  • [40] Retreatment of chronic hepatitis C patients with interferon plus ribavirin vs interferon alone
    Vandelli, C
    Renzo, F
    Vecchi, C
    Lovato, E
    Tisminetzky, S
    Ventura, E
    JOURNAL OF HEPATOLOGY, 2000, 32 : 191 - 191
12345